Salvianolate for injection
Function and Efficacy
Pharmacological experiments have shown that this product can reduce the degree of ST segment elevation on the electrocardiogram, reduce the infarct area, and reduce serum LDH in dogs with acute myocardial infarction caused by coronary artery ligation. It has a certain inhibitory effect on ADP-induced platelet aggregation in rats and has an inhibitory effect on arteriovenous bypass thrombosis in rats.
Ingredients
Salvianolate
Appearance
This product is a light brown loose lump with a slightly bitter and astringent taste.
Usage and Dosage
Intravenous drip. 200 mg at a time, dissolved in 250-500 ml of 5% glucose injection, once a day. The course of treatment is 2 weeks.
Adverse Reactions
A small number of patients experience dizziness, headache, and headache. Occasionally, patients experience mild headaches due to the fast drip rate during infusion.
Precautions
It is forbidden to mix with other medicines.
Drug Interactions
There is no information on the interaction of this product with other drugs.
Storage
Sealed and stored away from light.
Packaging Specification
Each bottle contains 200mg (containing 160mg of salvia miltiorrhiza magnesium acetate)
Validity Period
18 months